731部队原队员揭露细菌武器生产细节：我们的研究是为了把鼠疫菌变成武器，人体实验一直在做，生产的细菌总量足以毁灭整个人类

Core Viewpoint - The recent public disclosure of a complete interview with Sato Hideo, a member of the infamous Unit 731, provides critical evidence of the unit's development of biological weapons and inhumane human experimentation during the invasion of China [1][14]. Group 1: Biological Weapons Development - Sato Hideo stated that the research conducted by Unit 731 aimed to weaponize the plague bacteria, with over 1,000 animals, primarily guinea pigs and small rodents, being dissected to study the effects of the bacteria [2][5]. - The unit was known for breeding fleas from captured rats to create biological weapons, with plague-infected fleas being a key weapon due to their high lethality and wide infection range [3][5]. - The production capacity of the unit was significant, with claims of being able to produce 300 kilograms of plague bacteria per month, indicating a large-scale industrial operation for biological warfare [6][7]. Group 2: Human Experimentation - Sato Hideo openly admitted that human experimentation was ongoing, particularly in designated buildings that were heavily secured to maintain secrecy [10][13]. - The unit ensured that the human subjects used for experiments were kept in good health to obtain accurate data, reflecting a cold and calculated approach to their inhumane practices [11][13]. - The involvement of elite medical professionals from prestigious Japanese universities in these experiments highlights the systematic and organized nature of the crimes committed by Unit 731 [13][14]. Group 3: Systematic State Crime - The testimonies and evidence presented illustrate that the actions of Unit 731 were not isolated incidents but part of a broader, state-sponsored initiative driven by Japanese militarism [14]. - The comprehensive nature of the evidence, including Sato Hideo's firsthand accounts, reinforces the historical documentation of these war crimes and the necessity of remembering this history to prevent future atrocities [14].